Cargando…
Antigenic variation among murine coronaviruses: Evidence for polymorphism on the peplomer glycoprotein, E2
A panel of 28 monoclonal antibodies (MAb) against the structural proteins of murine hepatitis virus-4, strain JHM (MHV-4) was used in three antigen binding assays to determine the extent of antigenic homology among six strains of murine coronaviruses. The antigenic determinants studied were highly c...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
1985
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133991/ https://www.ncbi.nlm.nih.gov/pubmed/2412363 http://dx.doi.org/10.1016/0168-1702(85)90028-0 |
_version_ | 1783517740994134016 |
---|---|
author | Talbot, Pierre J. Buchmeier, Michael J. |
author_facet | Talbot, Pierre J. Buchmeier, Michael J. |
author_sort | Talbot, Pierre J. |
collection | PubMed |
description | A panel of 28 monoclonal antibodies (MAb) against the structural proteins of murine hepatitis virus-4, strain JHM (MHV-4) was used in three antigen binding assays to determine the extent of antigenic homology among six strains of murine coronaviruses. The antigenic determinants studied were highly conserved on the E1 glycoproteins and nucleocapsid (N) proteins of all strains tested. In contrast, antigenic polymorphism was observed among the E2 glycoproteins. Of three previously described antigenic determinants against which neutralizing antibodies are directed, only one, termed A(E2), was conserved on all strains. Antigenic site B(E2) was found only on the strongly neurotropic MHV-4 and site C(E2) was present on the virulent MHV-4 and MHV-3 (hepatotropic) strains, but absent on the weakly pathogenic MHV-A59, MHV-1 and MHV-S strains. Four non-neutralizing antibodies against at least one topographically distinct antigenic determinant, which we previously designated D(E2), gave binding patterns consistent with two distinct sites. One of these was present on all MHV strains tested and the other was present on all strains except MHV-S. These non-neutralizing antigenic sites were redesignated E(E2) and D(E2) respectively. |
format | Online Article Text |
id | pubmed-7133991 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1985 |
publisher | Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71339912020-04-08 Antigenic variation among murine coronaviruses: Evidence for polymorphism on the peplomer glycoprotein, E2 Talbot, Pierre J. Buchmeier, Michael J. Virus Res Article A panel of 28 monoclonal antibodies (MAb) against the structural proteins of murine hepatitis virus-4, strain JHM (MHV-4) was used in three antigen binding assays to determine the extent of antigenic homology among six strains of murine coronaviruses. The antigenic determinants studied were highly conserved on the E1 glycoproteins and nucleocapsid (N) proteins of all strains tested. In contrast, antigenic polymorphism was observed among the E2 glycoproteins. Of three previously described antigenic determinants against which neutralizing antibodies are directed, only one, termed A(E2), was conserved on all strains. Antigenic site B(E2) was found only on the strongly neurotropic MHV-4 and site C(E2) was present on the virulent MHV-4 and MHV-3 (hepatotropic) strains, but absent on the weakly pathogenic MHV-A59, MHV-1 and MHV-S strains. Four non-neutralizing antibodies against at least one topographically distinct antigenic determinant, which we previously designated D(E2), gave binding patterns consistent with two distinct sites. One of these was present on all MHV strains tested and the other was present on all strains except MHV-S. These non-neutralizing antigenic sites were redesignated E(E2) and D(E2) respectively. Published by Elsevier B.V. 1985-06 2002-11-12 /pmc/articles/PMC7133991/ /pubmed/2412363 http://dx.doi.org/10.1016/0168-1702(85)90028-0 Text en Copyright © 1985 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Talbot, Pierre J. Buchmeier, Michael J. Antigenic variation among murine coronaviruses: Evidence for polymorphism on the peplomer glycoprotein, E2 |
title | Antigenic variation among murine coronaviruses: Evidence for polymorphism on the peplomer glycoprotein, E2 |
title_full | Antigenic variation among murine coronaviruses: Evidence for polymorphism on the peplomer glycoprotein, E2 |
title_fullStr | Antigenic variation among murine coronaviruses: Evidence for polymorphism on the peplomer glycoprotein, E2 |
title_full_unstemmed | Antigenic variation among murine coronaviruses: Evidence for polymorphism on the peplomer glycoprotein, E2 |
title_short | Antigenic variation among murine coronaviruses: Evidence for polymorphism on the peplomer glycoprotein, E2 |
title_sort | antigenic variation among murine coronaviruses: evidence for polymorphism on the peplomer glycoprotein, e2 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133991/ https://www.ncbi.nlm.nih.gov/pubmed/2412363 http://dx.doi.org/10.1016/0168-1702(85)90028-0 |
work_keys_str_mv | AT talbotpierrej antigenicvariationamongmurinecoronavirusesevidenceforpolymorphismonthepeplomerglycoproteine2 AT buchmeiermichaelj antigenicvariationamongmurinecoronavirusesevidenceforpolymorphismonthepeplomerglycoproteine2 |